brimonidine tartrate

Generic: brimonidine tartrate

Labeler: florida pharmaceutical products, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name brimonidine tartrate
Generic Name brimonidine tartrate
Labeler florida pharmaceutical products, llc
Dosage Form SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

brimonidine tartrate 2 mg/mg

Manufacturer
Florida Pharmaceutical Products, LLC

Identifiers & Regulatory

Product NDC 71921-185
Product ID 71921-185_81960280-6045-44e8-a499-6f737a92c7f2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091691
Listing Expiration 2027-12-31
Marketing Start 2022-01-15

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] alpha-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71921185
Hyphenated Format 71921-185

Supplemental Identifiers

RxCUI
861200
UNII
4S9CL2DY2H

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brimonidine tartrate (source: ndc)
Generic Name brimonidine tartrate (source: ndc)
Application Number ANDA091691 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 2 mg/mg
source: ndc
Packaging
  • 5 mg in 1 BOTTLE, PLASTIC (71921-185-05)
  • 10 mg in 1 BOTTLE, PLASTIC (71921-185-10)
  • 15 mg in 1 BOTTLE, PLASTIC (71921-185-15)
source: ndc

Packages (3)

Ingredients (1)

brimonidine tartrate (2 mg/mg)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "81960280-6045-44e8-a499-6f737a92c7f2", "openfda": {"unii": ["4S9CL2DY2H"], "rxcui": ["861200"], "spl_set_id": ["a25f7abf-e066-4d16-a0ba-6150bdace81d"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 mg in 1 BOTTLE, PLASTIC (71921-185-05)", "package_ndc": "71921-185-05", "marketing_start_date": "20220115"}, {"sample": false, "description": "10 mg in 1 BOTTLE, PLASTIC (71921-185-10)", "package_ndc": "71921-185-10", "marketing_start_date": "20220115"}, {"sample": false, "description": "15 mg in 1 BOTTLE, PLASTIC (71921-185-15)", "package_ndc": "71921-185-15", "marketing_start_date": "20220115"}], "brand_name": "Brimonidine Tartrate", "product_id": "71921-185_81960280-6045-44e8-a499-6f737a92c7f2", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "71921-185", "generic_name": "Brimonidine Tartrate", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Brimonidine Tartrate", "active_ingredients": [{"name": "BRIMONIDINE TARTRATE", "strength": "2 mg/mg"}], "application_number": "ANDA091691", "marketing_category": "ANDA", "marketing_start_date": "20220115", "listing_expiration_date": "20271231"}